Alyeska Investment Group, L.P.

Position in FULC — Fulcrum Therapeutics, Inc.

CIK 1453072 CHICAGO, IL

Position in FULC

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$10,189,203

+$8,935,886 QoQ

Shares Held

1,328,449

+557.2% QoQ

Ownership

1.99%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#18

of 168 holders

Holding Since

Sep 2020

8 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Alyeska Investment Group, L.P. holds $1,219,709,732 across 81 Biotechnology names. FULC ranks #21 (0.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRNA	Moderna, Inc.	4,051,185	$205,800,198
2	RVMD	Revolution Medicines, Inc.	1,885,821	$183,396,092
3	JAZZ	Jazz Pharmaceuticals plc	411,015	$77,702,385
4	XENE	Xenon Pharmaceuticals Inc.	1,299,469	$75,564,122
5	PTGX	Protagonist Therapeutics, Inc	593,197	$62,522,963
6	DNLI	Denali Therapeutics Inc.	1,941,123	$37,269,561
7	IONS	Ionis Pharmaceuticals Inc	473,150	$35,528,833
8	TECH	BIO-TECHNE Corp	659,049	$34,441,900

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$10,189,203	1,328,449	+557.2%	Shares	Sole	2026-05-15
2024-06-30	$1,253,317	202,148	0.0%	Shares	Sole	2024-08-14
2024-03-31	$1,908,277	202,148	0.0%	Shares	Sole	2024-05-15
2023-12-31	$1,364,499	202,148	0.0%	Shares	Sole	2024-02-14
2023-09-30	$897,537	202,148	0.0%	Shares	Sole	2023-11-14
2023-06-30	$667,088	202,148	+32.9%	Shares	Sole	2023-08-14
2023-03-31	$433,621	152,148	-27.1%	Shares	Sole	2023-05-15
2020-09-30	$1,655,443	208,757	—	Shares	Sole	2020-11-16
No filing history on record for this holder in this stock.